We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+7.59%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$139M
AUM Growth
+$23.3M
Cap. Flow
+$16.7M
Cap. Flow %
12.01%
Top 10 Hldgs %
43.14%
Holding
146
New
22
Increased
66
Reduced
44
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 14.37%
2 Communication Services 10.31%
3 Technology 9.61%
4 Industrials 3.86%
5 Consumer Discretionary 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.5T
$1.25M 0.9%
11,922
+2,437
+26% +$250K
SLYV icon
27
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.02B
$1.24M 0.89%
26,760
+10,838
+68% +$538K
LABU icon
28
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$556M
$1.15M 0.83%
+683
New +$1.11M
PGEN icon
29
Precigen
PGEN
$2.46B
$1.15M 0.83%
38,431
+8,486
+28% +$286K
PRTA icon
30
Prothena Corp
PRTA
$444M
$1.1M 0.79%
16,123
+425
+3% +$25.6K
EFA icon
31
iShares MSCI EAFE ETF
EFA
$79.4B
$1.08M 0.78%
18,448
-1,797
-9% -$108K
IBB icon
32
iShares Biotechnology ETF
IBB
$9.47B
$1.07M 0.77%
9,498
+1,425
+18% +$155K
GE icon
33
GE Aerospace
GE
$396B
$1.07M 0.77%
7,151
+890
+14% +$126K
BRK.B icon
34
Berkshire Hathaway Class B
BRK.B
$1.12T
$1.01M 0.73%
7,679
+2,767
+56% +$371K
BIIB icon
35
Biogen
BIIB
$30.5B
$976K 0.7%
3,187
-104
-3% -$29.9K
JPM icon
36
JPMorgan Chase
JPM
$955B
$950K 0.68%
14,397
+2,049
+17% +$133K
V icon
37
Visa
V
$688B
$947K 0.68%
12,212
+578
+5% +$44.8K
NMZ icon
38
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.19B
$919K 0.66%
66,533
+104
+0.2% +$1.42K
PFE icon
39
Pfizer
PFE
$147B
$888K 0.64%
29,023
-942
-3% -$29.6K
MIDU icon
40
Direxion Daily Mid Cap Bull 3X ETF
MIDU
$73.4M
$830K 0.6%
39,926
+275
+0.7% +$6.17K
TNA icon
41
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.43B
$823K 0.59%
25,936
+2,956
+13% +$101K
STZ icon
42
Constellation Brands
STZ
$22.3B
$794K 0.57%
5,580
+1,421
+34% +$196K
LUV icon
43
Southwest Airlines
LUV
$23.9B
$771K 0.55%
17,912
+1,390
+8% +$61.6K
MMM icon
44
3M
MMM
$93.9B
$731K 0.53%
5,809
+2,735
+89% +$352K
MO icon
45
Altria Group
MO
$114B
$725K 0.52%
12,459
+1,796
+17% +$104K
IWC icon
46
iShares Micro-Cap ETF
IWC
$1.5B
$687K 0.49%
9,535
-4,244
-31% -$313K
BMY icon
47
Bristol-Myers Squibb
BMY
$130B
$683K 0.49%
9,929
-531
-5% -$35.1K
FIDU icon
48
Fidelity MSCI Industrials Index ETF
FIDU
$2.39B
$676K 0.49%
24,854
+756
+3% +$20.8K
GT icon
49
Goodyear
GT
$1.99B
$673K 0.48%
20,604
+2,972
+17% +$97.5K
JNJ icon
50
Johnson & Johnson
JNJ
$621B
$650K 0.47%
6,334
+1,758
+38% +$177K

Similar funds

Traynor Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Traynor Capital Management held 146 positions worth $139M, up 20% from $116M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Traynor Capital Management deployed $16.7M of net new capital in Q4 2015, opening 22 new positions and adding to 66 existing holdings. Its largest new stake was Alphabet (Google) Class A: 135,380 shares worth $5.27M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $3.66M trimmed.

  • Traynor Capital Management's largest Q4 2015 buy was Alphabet (Google) Class A: 135,380 shares worth $5.27M.
  • Traynor Capital Management added most to Amazon in Q4 2015, an estimated $1.44M increase.
  • Traynor Capital Management's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $3.66M.
  • Traynor Capital Management fully exited Barclays Bank Plc Series 3 in Q4 2015, selling an estimated $285K.
  • Traynor Capital Management's ten largest holdings make up 43% of its $139M portfolio in Q4 2015.
  • Traynor Capital Management opened 22 new positions and closed 7 in Q4 2015.
  • Traynor Capital Management's portfolio value rose 20% quarter-over-quarter to $139M.

Based on Traynor Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.